Page last updated: 2024-08-18

4-butyrolactone and ER-Negative PR-Negative HER2-Negative Breast Cancer

4-butyrolactone has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Aryandono, T; Chao, TY; Deng, L; Fong, IH; Haryana, SM; Huang, CC; Huang, WC; Lin, CC; Liu, HW; Ong, JR; Satriyo, PB; Su, CM; Tzeng, YM; Yeh, CT1
Chen, X; De, S; Rotenberg, SA; Tsimounis, A1

Other Studies

2 other study(ies) available for 4-butyrolactone and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells.
    Toxicology and applied pharmacology, 2021, 07-01, Volume: 422

    Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclohexanones; DNA Damage; DNA Repair; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred NOD; Mice, SCID; Signal Transduction; Triple Negative Breast Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays

2021
Phosphorylation of α-tubulin by protein kinase C stimulates microtubule dynamics in human breast cells.
    Cytoskeleton (Hoboken, N.J.), 2014, Volume: 71, Issue:4

    Topics: 4-Butyrolactone; Breast; Cell Line, Transformed; Cell Movement; Cell Survival; Enzyme Activation; Female; Fluorescent Antibody Technique; Green Fluorescent Proteins; Humans; Microtubule-Associated Proteins; Microtubules; Models, Biological; Mutant Proteins; Neoplasm Metastasis; Phosphorylation; Phosphoserine; Protein Kinase C; rac1 GTP-Binding Protein; Recombinant Fusion Proteins; Triple Negative Breast Neoplasms; Tubulin; Valerates

2014